QTXB Financials 07/16/2014 11:09:18 QuantRX Biome
Post# of 4
QuantRX Biomedical Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 6 15 19 64
Cost of Revenue 1 - - -
Gross Profit 6 15 19 63
Operating Expenses
Research and Development 28 25 48 282
Sales, General and Admin. 345 474 734 1,714
Non-Recurring Items - - - -
Other 9 10 34 73
Operating Income (377) (494) (797) (2,006)
Income From Continuing Operations
Add'l Income/Expense Items (11) (314) 249 2,907
Earnings Before Interest and Tax (301) (693) (548) 901
Interest Expense 57 25 7 7
Earnings Before Tax (358) (718) (554) 894
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary 87 116 - -
Net Income Cont. Operations (271) (602) (554) 894
Non Recurring Events
Discontinued Operations - - (229) (63)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (358) (718) (784) 831
Preferred Stock and Other Adjustments - - - (388)
Net Income Applicable to Common Shareholders (358) (718) (784) 443